• 11-01-2021

DeepIntent Survey Reveals That Pharmaceutical Advertising Motivates Patients to Research Treatment and Medication Options

DeepIntent surveyed 1,244 U.S. patients in August 2021 about their attitudes toward pharmaceutical ads and whether they find them relevant.

In this article, Pharmaceutical Executive Magazine shares key takeaways from the survey revealing how advertising motivates patients to research their treatment and medication options. DeepIntent’s CEO Chris Paquette also shares the opportunities healthcare marketers can act on as a result of this research.

Read more here.

More News

Article
Using Technology to Advance Health Equity: A New Solution for Reaching Underserved Communities
6-27-2025
Despite years of progress in healthcare innovation, too many patients in North America still face barriers to care that stem not from biology, but...
Read More
Article
6 Healthcare Marketing Takeaways from Cannes Lions 2025
6-27-2025
Last week, Cannes Lions 2025 brought together the global advertising industry for a week of high-profile programming, creative celebration, and perhaps most importantly, meaningful...
Read More
Article
Why DTC Pharmaceutical Advertising Shouldn’t Be Banned
6-18-2025
Last week, a new bill called the “End Prescription Drug Ads Now Act” was introduced in Congress, aiming to ban nearly all direct-to-consumer (DTC)...
Read More